New Jersey-based company Braeburn Pharmaceuticals recently developed an implantable device called probuphine, intended to treat opiate addiction in the same way as Suboxone – without such an extreme potential for abuse. The device is composed of four metal rods, each which slowly seep buprenorphine (a semisynthetic opioid medication) and are no larger than a matchstick.
The New Standard for Treatment In a move that’s sure to raise more than a few eyebrows, SAMHSA has officially endorsed medication-assisted therapies (also known as opioid replacement therapies). While they’ve long been supporters of buprenorphine (Suboxone and Subutex) and methadone, the Substance Abuse and Mental Health Services Administration recently added wording to their grant
An Innovative Solution to an Old Problem Anne Arundel County, located just south of Baltimore, is tight in the grip of this country’s heroin epidemic. Consider that there were forty-eight overdose deaths in 2014 alone. Consider that there were 204 heroin related ER visits in 2013 alone. Consider that Steve Schuh, the County Executive, declared
How Long Does Suboxone Last? Medication assisted therapies, opioid replacement therapies, methadone and buprenorphine maintenance…there are a lot of options when it comes to using medicine to recover from addiction. The most popular option over the past several years has been, by far, Suboxone maintenance. With dedicated buprenorphine doctors and “sub clinics” opening all over
Suboxone Withdrawal Getting off Suboxone stinks. That’s the simple truth about coming off this opioid. Suboxone withdrawal symptoms are unpleasant and last for longer than “normal” opioid withdrawal. Subutex withdrawal isn’t much better (I explore the differences between the two below). I say this as a former addict and someone who now works in addiction
A New Approach to Drug Court In a move that’s sure to ruffle some feathers, the federal government is throwing its weight around to make Suboxone mandatory in many drug courts. According to Michael Botticelli, the Director of the White House’s Office of National Drug Control Policy, the government will begin to cut off federal